Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
24
NCT03869983
Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection
Phase: N/A
Role: Lead Sponsor
Start: Apr 12, 2019
Completion: Jun 15, 2019
NCT04627831
Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
Phase: Phase 2
Role: Collaborator
Start: Jan 31, 2022
Completion: Apr 30, 2023